Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA (2008)

Approval Year: 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | All Years


The following drugs have been approved this year by the Food and Drug Administration.

Cardiology/Vascular Diseases

    No approvals recorded to date in this area.

Dental/Maxillofacial Surgery

    No approvals recorded to date in this area.

Dermatology/Plastic Surgery

    No approvals recorded to date in this area.

Endocrinology

Gastroenterology
  • Rotarix (Rotavirus Vaccine, Live, Oral); For the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in pediatrics; GlaxoSmithKline; Approved April 2008
  • Tysabri (natalizumab); For the maintenance treatment of moderate to severe Crohn’s disease; Biogen IDEC; Approved January 2008

Hematology

    No approvals recorded to date in this area.

Immunology/Infectious Diseases
  • Intelence (etravirine); For the treatment of HIV-1; Tibotec; Approved January 2008
  • Moxatag (amoxicillin); For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics; MiddleBrooke Pharmaceuticals; Approved January 2008
  • Rotarix (Rotavirus Vaccine, Live, Oral); For the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in pediatrics; GlaxoSmithKline; Approved April 2008
  • Tysabri (natalizumab); For the maintenance treatment of moderate to severe Crohn’s disease; Biogen IDEC; Approved January 2008

Musculoskeletal
  • Orencia (abatacept); For the treatment of Juvenile Idiopathic Arthritis; Bristol-Myers Squibb; Approved April 2008[*]

Nephrology/Urology

    No approvals recorded to date in this area.

Neurology

    No approvals recorded to date in this area.

Obstetrics/Gynecology

    No approvals recorded to date in this area.

Oncology

Ophthalmology

    No approvals recorded to date in this area.

Otolaryngology
  • Moxatag (amoxicillin); For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics; MiddleBrooke Pharmaceuticals; Approved January 2008
  • Patanase (olopatadine hydrochloride); For the treatment of seasonal allergic rhinitis; Alcon; Approved April 2008

Pediatrics/Neonatology
  • Accretropin (somatropin rDNA Original); For the treatment of growth failure in pediatrics; Cangene Corp; Approved January 2008
  • Alvesco (ciclesonide); For the maintenance treatment of asthma as prophylactic therapy in adults and adolescents; Nycomed; Approved January 2008
  • Moxatag (amoxicillin); For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics; MiddleBrooke Pharmaceuticals; Approved January 2008
  • Orencia (abatacept); For the treatment of Juvenile Idiopathic Arthritis; Bristol-Myers Squibb; Approved April 2008[*]
  • Patanase (olopatadine hydrochloride); For the treatment of seasonal allergic rhinitis; Alcon; Approved April 2008
  • Rotarix (Rotavirus Vaccine, Live, Oral); For the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in pediatrics; GlaxoSmithKline; Approved April 2008

Pharmacology/Toxicology

    No approvals recorded to date in this area.

Psychiatry/Psychology

    No approvals recorded to date in this area.

Pulmonary/Respiratory Diseases

Rheumatology
  • Orencia (abatacept); For the treatment of Juvenile Idiopathic Arthritis; Bristol-Myers Squibb; Approved April 2008[*]

Trauma/Emergency Medicine

    No approvals recorded to date in this area.


Back to Centerwatch Drug Directories

Drug listings last updated: May 9, 2008 at 12:22:56 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA